Quantcast

Latest cell therapy Stories

2014-07-14 16:24:23

Yesenia Torres regained some mobility and sensation in her body after a car accident left her paralyzed from the chest down at the age of 21. NEW YORK, July 14, 2014 /PRNewswire/ -- Yesenia Torres was an outgoing, popular teenager, with the body of an athlete. the face of a model, and long, beautiful hair. She was turning heads wherever she went. And then a car accident changed her life forever. Like typical 21 year olds, Yesenia and her two girlfriends were taking a road trip to...

2014-07-09 12:30:16

LONDON, July 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Induced Pluripotent Stem Cells : Global Marketshttps://www.reportbuyer.com/product/2212008/Induced-Pluripotent-Stem-Cells--Global-Markets.html This BCC Research report provides detailed market and industry analyses to help readers quantify and qualify the global market for induced pluripotent stem cells (iPSCs). Important trends of the field and market segments are identified, and market sizes...

2014-07-08 11:11:21

Journal of Neurosurgery Publishing Group A spinal mass was identified in a young woman with complete spinal cord injury 8 years after she had undergone implantation of olfactory mucosal cells in the hopes of regaining sensory and motor function. The case is reported and discussed in "Autograft-derived spinal cord mass following olfactory mucosal cell transplantation in a spinal cord injury patient. Case report," by Brian J. Dlouhy, MD, Olatilewa Awe, MD, Rajesh C. Rao, MD, Patricia A....

2014-07-08 08:32:11

SAN DIEGO, July 8, 2014 /PRNewswire/ -- ViaCyte, Inc. ("ViaCyte"), a privately held regenerative medicine company developing a cell therapy for treatment of type I diabetes, today announced it has received International Standards Organization (ISO) 13485:2003 certification, an internationally recognized quality standard for medical devices. ViaCyte's certification was awarded by the British Standards Institution (BSI), one of the world's leading certification bodies....

2014-07-07 12:29:12

- Designation supports the advancement of CTL019 to help address the unmet need of patients with relapsed/refractory acute lymphoblastic leukemia (r/r ALL) EAST HANOVER, N.J., July 7, 2014 /PRNewswire/ -- Novartis announced today that the United States Food and Drug Administration (FDA) has granted Breakthrough Therapy status to CTL019, an investigational chimeric antigen receptor (CAR) therapy for the treatment of pediatric and adult patients with relapsed/refractory acute lymphoblastic...

2014-07-07 10:28:28

Neural Regeneration Research Researchers at the University of Birmingham, UK, led by Dr. Ben Scheven, Dr. Wendy Leadbeater and Ben Mead have discovered that stem cells isolated from the teeth, termed dental pulp stem cells (DPSC), can protect retinal ganglion cells (RGCs) from death following injury and promote regeneration of their axons along the optic nerve. RGC loss is the leading cause of blindness and can arise through traumatic injury or degenerative diseases such as glaucoma....

2014-07-01 16:29:20

TEL AVIV, Israel and NEW YORK, July 1, 2014 /PRNewswire/ -- Cell Source, Inc. (OTCQB: CLCS) ("Cell Source") today announced the successful acquisition (the "Acquisition"), through a share exchange agreement, of all of the outstanding shares of Cell Source (Israel) Ltd., a pre-clinical cell therapy development company with a focus on the facilitation of safer and more accessible bone marrow and organ transplants and effective treatment of blood cell cancers (e.g., leukemia,...

2014-07-01 11:10:06

American Association for Cancer Research A new approach demonstrated that the recognition of unique cancer mutations appeared to be responsible for complete cancer regressions in two metastatic melanoma patients treated with a type of immunotherapy called adoptive T-cell therapy. This new approach may help develop more effective cancer immunotherapies, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research. "This study...

2014-07-01 11:00:54

HSC Mesenchymal stem cells have become attractive tools for bioengineers, but some scientists haven’t given up on their regenerative potential Stem cell scientists had what first appeared to be an easy win for regenerative medicine when they discovered mesenchymal stem cells several decades ago. These cells, found in the bone marrow, can give rise to bone, fat, and muscle tissue, and have been used in hundreds of clinical trials for tissue repair. Unfortunately, the results of these...

2014-06-30 08:31:42

GERMANTOWN, Md., June 30, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) reports that its shares have been added to the broad-market Russell 3000(®) Index. Annual reconstitution of Russell's U.S. indexes captures the 4,000 largest U.S. stocks as of the end of May, ranking them by total market capitalization. Membership in the Russell 3000, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000(®) Index or small-cap Russell 2000(®) Index...


Word of the Day
cock-a-hoop
  • Exultant; jubilant; triumphant; on the high horse.
  • Tipsy; slightly intoxicated.
This word may come from the phrase 'to set cock on hoop,' or 'to drink festively.' Its origin otherwise is unclear. A theory, according to the Word Detective, is that it's a 'transliteration of the French phrase 'coq a huppe,' meaning a rooster displaying its crest ('huppe') in a pose of proud defiance.' Therefore, 'cock-a-hoop' would 'liken a drunken man to a boastful and aggressive rooster.'
Related